IQVIA™ Real-World Insights Bibliography

Identification of a hereditary angioedema cohort in a US ambulatory EMR database
Author(s): Brouwer E, Bratton E, Near A, Lang K, Mack C
Affiliations(s): 
Publication(s):  Pharmacoepidemiol Drug Saf 2018; 27 (2): 136-137.
Document Type(s): Poster,
Countries: 
C:
Y:
Rare Diseases,
2018
  L:
A:
English
  Add to report
 
 
Rare disease development programs: An update
Author(s): Wu J, Want C, Horton DB, Petersen I, Oliveria S, Blackburn S, Jiang J, LoCasale R.
Affiliations(s): 
Publication(s):  Pharmacoepidemiol Drug Saf 2018; 27 (2):5.
Document Type(s): Poster,
Countries: 
C:
Y:
Rare Diseases,
2018
  L:
A:
English
  Add to report
 
 
WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE.
Author(s): Moutier Hélène; Bourguignon Sandrine; Maurel Frédérique; Bodaghi Charles
Affiliations(s): RWI IQVIA France
Publication(s):  ISPOR 2018
Document Type(s): Poster,
Countries: France,
C:
Y:
Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases,
2018
  L:
A:
English
Cost effectiveness, Pricing & Reimbursement, Willingness to pay,
  Add to report
 
 
Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus
Author(s): Kabadi S, Yeaw J, Bacani AK, Tafesse E, Bos K, Karkare S, DeKoven M, Vina ER
Affiliations(s): AstraZeneca, IQVIA
Publication(s):  Lupus
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Rare Diseases,
2018
  L:
A:
English
Cost analysis, Retrospective cohort analysis,
  Add to report
 
 
Health Care Resource Utilization Among a US Cohort Treated for Hereditary Angioedema, 2010?2015
Author(s): Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G.
Affiliations(s): Tachdjian R: UCLA School of Medicine; Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire
Publication(s):  2018 American Academy of Allergy, Asthma and Immunology (AAAAI)/World Allergy Organization (WAO) Joint Congress
Document Type(s): Poster,
Countries: USA,
C:
Y:
Patient Registries & Real-World Study Methods, Rare Diseases,
2018
  L:
A:
English
Cost analysis, Database Study, Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Demographic Characteristics and Treatment Patterns among Patients Treated for Hereditary Angioedema in a U.S. Cohort, 2006-2015
Author(s): Tachdjian R, Johnson KE, Casso D, Oliveria SA, Devercelli G, Jain G
Affiliations(s): Tachdjian R: UCLA School of Medicine (Department of Medicine and Pediatrics), Johnson KE: IQVIA (formerly); Casso D: IQVIA; Oliveria SA: IQVIA; Devercelli G: Shire; Jain G: Shire.
Publication(s):  34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Type(s): Abstract,
Countries: USA,
C:
Y:
Rare Diseases,
2018
  L:
A:
English
Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project
Author(s): Rito Bergemann, James Allsopp, Harvey Jenner, Flora Ashley Daniels, Edmund Drage, Yevgeniy Samyshkin, Claude Schmitt, Steven Wood, David G. Kiely, Allan Lawrie
Affiliations(s): "1GlaxoSmithKline, Brentford, Middlesex, UK 2Current affiliation: Evalueserve Life Sciences Healthcare, London, UK 3Scientific Computing Group, Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK 4IQVIA, London, UK 5Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK 6National Pulmonary Hypertension Service (Sheffield), Sheffield Pulmonary Vascular Unit, Royal Hallamshire Hospital, Sheffield, UK 7INSIGNEO, University of Sheffield, Sheffield, UK"
Publication(s):  Pulm Circ. 2018 Oct-Dec;8(4):2045894018798613. doi: 10.1177/2045894018798613.
Document Type(s): Article,
Countries: UK,
C:
Y:
Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Real world data from hospital episode statistics can be used to determine patients at risk of idiopathic pulmonary arterial hypertension
Author(s): "David G. Kiely MD, Allan Lawrie, Orla Doyle PhD, Valentina Salvatelli PhD, Flora Ashley Daniels PhD, Edmund Drage, Harvey Jenner, John Rigg, Claude Schmitt, Yevgeniy Samyshkin, Rito Bergemann "
Affiliations(s): 1Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK; 2Real-World & Analytical Solutions, IQVIA, London, UK; 3GSK, Brentford, Middlesex, UK; 4Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK; 5INSIGNEO, University of Sheffield, Sheffield, UK; 6Evalueserve UK Ltd, London, UK. 1 Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, UK. 2 Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK. 3 INSIGNEO, University of Sheffield, Sheffield, UK. 4 Real-World & Analytical Solutions, IQVIA, London, UK. 5 GlaxoSmithKline, Brentford, Middlesex, UK.
Publication(s):  European Respiratory Journal 2018 52: Suppl. 62, PA3082.
Document Type(s): Poster,
Countries: UK,
C:
Y:
Cardiovascular disease, Database Validity and methodology, Rare Diseases, Respiratory disease,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings
Author(s): De Bortoli N1, Ripellino C2, Cataldo N3, Marchi S1
Affiliations(s): 1 Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy 2 Department of Real World Evidence, HEOR Consultant Freelance, Milan, Italy 3 Department of Real World Evidence, QuintilesIMS, Milan, Italy
Publication(s):  Expert Opinion on Drug Safety. doi: 10.1080/14740338.2017.1376647. [Epub ahead of print]
Document Type(s): Article,
Countries: Germany, Italy,
Click here for the abstract
C:
Y:
Drug safety, Gastrointestinal disorders, Rare Diseases,
2017
  L:
A:
English
Clinical setting: Primary care, Database Study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
CLOSING THE EVIDENCE GAP FOR ORPHAN DRUGS: DO GERMAN REGULATORY REQUIREMENTS GIVE INCENTIVES FOR HIGH LEVEL EVIDENCE GENERATION?
Author(s): Ana Babac, Roger-Axel Greiner, Doreen Bonduelle
Affiliations(s): "QuintilesIMS, IMS Health GmbH & Co. OHG, Landshuter Allee 10, 80637 München "
Publication(s):  ISPOR 20th Annual European Congress, Glasgow
Document Type(s): Poster,
Countries: Germany,
Click here for the abstract
C:
Y:
Rare Diseases,
2017
  L:
A:
English
Pricing & Reimbursement, Retrospective database analysis,
  Add to report
 
 
 1 of 2 Next Page Last Page